What is Plexision?
Headquartered in Pittsburgh, Pennsylvania, Plexision operates at the intersection of biotechnology and clinical diagnostics. The company specializes in the development of sophisticated cellular biomarkers designed to provide actionable insights into solid organ transplantation and complex immunological disorders. With a portfolio of FDA-approved blood tests, Plexision provides critical data that assists clinicians in predicting transplant rejection risks and evaluating cellular immunity against viral pathogens. Beyond its diagnostic suite, the company maintains a CLIA-certified laboratory, enabling it to support pharmaceutical partners through custom research and development projects that integrate biomarker targets across the entire drug development lifecycle.
How much funding has Plexision raised?
Plexision has raised a total of $406K across 2 funding rounds:
Debt
$41K
Other Financing Round
$365K
Debt (2021): $41K with participation from PPP
Other Financing Round (2025): $365K led by Richard King Mellon Foundation
Key Investors in Plexision
Richard King Mellon Foundation
A prominent philanthropic organization focused on enhancing prosperity in Southwestern Pennsylvania through strategic grants and program-related investments in health and well-being.
PPP
Public-Private Partnership
What's next for Plexision?
With this recent capital injection, Plexision is poised to scale its operational capacity and expand its footprint in the personalized medicine market. The strategic focus will likely shift toward broadening the clinical utility of its existing biomarker platform and deepening its engagement in drug development partnerships. As the demand for precision diagnostics in transplant medicine continues to rise, the company is strategically aligned to leverage its proprietary technology to address unmet needs in patient care and therapeutic efficacy. Future growth will be defined by the successful commercialization of its diagnostic pipeline and the continued integration of its biomarker solutions into standard clinical workflows.
See full Plexision company page
